For the development of the new biomarkers using the technique of Mass-spectrometry 7, 5 ml EDTA blood and a dry blood spot filter card are taken. To proof the correct diagnosis of a cystic fibrosis in those patients where up to the enrollment in the study no genetic testing has been done, sequencing of a cystic fibrosis disease will be done.